Home > Insider Trading > Filing (0001567619-19-012602)

Filing Details

Accession Number:: 0001567619-19-012602
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-06-03 17:15:00
Reporting Period:: 2019-05-28

Accepted Time:: 2019-06-03 17:15:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1761612	Bicycle Therapeutics Plc	BCYC	()	K3

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1553936	Ltd (Hk) Management Capital Tybourne	30/F, Aia Central, 1 Connaught Road C Hong Kong K3 XXXXX	No	No	Yes	No
1680760	Ltd Kesari Tybourne	30/F, Aia Central, 1 Connaught Road C Hong Kong K3 XXXXX	No	No	Yes	No
1680784	Ltd Management Capital Tybourne	30/F, Aia Central, 1 Connaught Road C Hong Kong K3 XXXXX	No	No	Yes	No
1680820	Viswanathan Krishnan	30/F, Aia Central, 1 Connaught Road C Hong Kong K3 XXXXX	No	No	Yes	No
1777368	Iv Investments Aquila	C/O Bicycle Therapeutics 30/F Aia Central 1 Connaught Road Hong Kong K3 XXXXX	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2019-05-28	1,454,411	$0.00	1,454,411	No	4	C	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2019-05-28	139,264	$0.00	1,593,675	No	4	X	Indirect	See Footnotes
Ordinary Shares	Acquisiton	2019-05-28	364,286	$14.00	1,957,961	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnotes
No	4	X	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Series B2 Preferred Shares	Disposition	2019-05-24	1,454,411	$0.00	1,454,411	$0.00
Ordinary Shares	Series B2 Preferred Shares Warrants	Disposition	2019-05-28	139,264	$0.00	139,264	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	X	Indirect

Footnotes

Each Series B1 Preferred Share and Series B2 Preferred Share of the Issuer automatically converted into Ordinary Shares of the Issuer on a one for 1.429 basis immediately prior to the closing of the Issuer's initial public offering. The preferred shares had no expiration date. The number of shares reported with respect to preferred shares of the Issuer reflects the conversion of the Series B1 Preferred Shares and Series B2 Preferred Shares to Ordinary Shares set out in Footnote (1).
The warrants to purchase Series B1 Preferred Shares became exercisable for the number of Ordinary Shares into which Series B1 Preferred Shares became convertible immediately prior to the closing of the Issuer's initial public offering. The warrants had an exercise price of GBP 0.01 per share, and were exercised immediately prior to the closing of the Issuer's initial public offering.
These securities are held for the benefit of Aquila Investments IV, a private investment fund for which Tybourne Capital Management (HK) Limited ("Tybourne HK") serves as investment advisor.
These securities are held for the benefit of other private investment funds and accounts for which Tybourne HK serves as investment advisor.
Tybourne Capital Management Limited ("Tybourne Cayman") is the parent of Tybourne HK. Tybourne Kesari Limited ("Tybourne Kesari") is the parent of Tybourne Cayman. Mr. Krishnan is the principal and sole shareholder of Tybourne Kesari. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or his pecuniary interest in such shares, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
This report does not include any pecuniary interest of Bosun Hau in securities of the Issuer. Mr. Hau, Managing Director and Principal - Private Markets at Tybourne HK, separately files reports under Section 16.